entity

Aria

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Aria: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

2Connections
2Hypotheses
6Analyses
1Outgoing
1Incoming

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Anti-Amyloid Immunotherapy Comparison Matrix for Alzheimer's Disease

therapeutic · 1258 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

nhp-validation-animal-model

general · 5820 words

rasagiline

therapeutic · 4916 words

DIAN-TU-001 Trial (NCT01760005)

clinical · 4560 words

A Phase 3, Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Tolerability, and Safety of Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease

clinical · 4279 words

Outgoing (1)

TargetRelationTypeStr
Cerebral Amyloid Angiopathyassociated_withdisease0.80

Incoming (1)

SourceRelationTypeStr
Amyloid-Beta Aggregationmediatesprocess0.80

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Smartphone-Detected Motor Variability Correction 0.563 neurodegeneration Digital biomarkers and AI-driven early d
TREM2 R47H Variant Correction — AAV-Mediated Rescue of Commo 0.452 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro

Mentioning Analyses (6)

Scientific analyses that reference this entity

Why does iron chelation therapy worsen outcomes in H63D HFE variant carriers des

neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586

Why does the V1613M variant reduce amyloid pathology when ABCA7 loss-of-function

neurodegeneration | 2026-04-14 | 2 hypotheses Top: 0.619

Can circadian interventions reverse microglial priming independent of sleep disr

chronobiology | 2026-04-08 | 0 hypotheses

What molecular mechanisms drive tissue-specific phenotypes in Mendelian neurolog

neurodegeneration | 2026-04-08 | 0 hypotheses

What are the specific molecular mechanisms by which AQP4 dysfunction contributes

neurodegeneration | 2026-04-07 | 0 hypotheses

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmaco [PMID:34106485] Cacabelos R, Carrera I, Martínez O, Alej Med Res Rev 2021 1
Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation [PMID:31120439] Luo Z, Ahlers-Dannen KE, Spicer MM, Yang JCI Insight 2019 1
Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant [PMID:31873106] Yedlapudi D, Xu L, Luo D, Marsh GB, Todi Sci Rep 2019 1
A systematic review and integrative approach to decode the common molecular link [PMID:28927418] Guin D, Mishra MK, Talwar P, Rawat C, Ku BMC Med Genomics 2017 1
The role of genetic factors in the occurrence of levodopa-induced motor complica [PMID:40632937] ["Radojevi\u0107 B", "Milovanovi\u0107 A Neurological research 2026 0
Reliability and Discriminant Ability of an Instrumented Timed Up and Go Test in [PMID:41921127] ["Giardini M", "Arcolin I", "Arcobelli V JMIR rehabilitation and assist 2026 0
The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei Neuron 2026 0
Role of TREM2 in neuroinflammation. [PMID:41213496] Abdulkhaliq AA, Alasiri G, Almoghrabi Y, Exp Neurol 2026 0
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] Zhang J, St Pierre Schneider B, Muguerza Am J Physiol Endocrinol Metab 2026 0
Diankuang Mengxing Decoction exerts neuroprotective effects in post-stroke depre [PMID:41534750] Yang X, Zhao Y, Liu W, Feng J, Wu X et a J Ethnopharmacol 2026 0
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] Mateus-Tique J, Lakshmi A, Singh B, Iyer Cancer Cell 2026 0
Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] Li X, Tang X, Zeng J, Duan L, Hou Z et a Cell 2026 0
TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] Feiten AF, Dahm K, Schlepckow K, van Len Nat Commun 2026 0
Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] Xia P, Shuang S, Fu D, Liu L, Yang D et NPJ Precis Oncol 2026 0
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] Zhao Q, Huang R, Wang C, Hu J, Nie R et Cancer Cell 2026 0
TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] Yang HC, Deng YS, Zhang J, Zhang T, Song J Alzheimers Dis 2026 0
Hierarchical Targeting of TREM2(+) Myeloid Cells via Acid-Triggered OMVs Reprogr [PMID:41945876] Chen F, Xue Y, Ma X, Chen L, Shao Z et a Adv Sci (Weinh) 2026 0
Correction to "A Strategy Involving Microporous Microneedles Integrated with CAR [PMID:41952643] Unknown Advanced materials (Deerfield 2026 0
TREM2 in neurodegeneration and diseases. [PMID:41792456] ["Abdulkhaliq A", "Alasiri G", "Kim B", Molecular psychiatry 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] Aranda-Abreu GE, Rojas-Durán F, Hernánde Neurology international 2026 0